NVIDIA Corporation (NASDAQ:NVDA): Despite weakening PC demand, Cannacord’s checks with NVIDIA’s upstream partners are still positive. The firm believes that NVIDIA will maintain guidance which will support shares before new product launches. Shares have a Buy rating and a $16 price target.
Microsoft Corporation (NASDAQ:MSFT) Q4 results will be supported by the Windows 7 corporate refresh and maintenance, according to Bernstein’s predictions. The firm keeps an Outperform rating on the shares.
Cavium Networks, Inc. (NASDAQ:CAVM): The recent pullback in the company’s shares are viewed by Jefferies as a buying opportunity since channel checks suggested positive near-term order trends as well as a favorable competitive landscape. The firm recommends purchasing shares because of the recent weakness and maintains a Buy rating with a $35 price target on the stock.
Cubist Pharmaceuticals Inc. (NASDAQ:CBST) have been pricing in little to no value for the Phase 3 drug candidates for the company, according to Jefferies who also views the current valuation as attractive. The firm keeps a Buy rating and $50 price target on the stock.
C&J Energy Services Inc (NYSE:CJES) valuation range was lowered by Wells Fargo due to the firm’s belief that the the falling spot pricing in its market is more likely to harm the company rather than help, but the firm also sees a number of positive trends. The firm keeps an Outperform rating on the stock.
Investing Insights: Fastenal Earnings CHEAT SHEET: Double-Digit Growth AGAIN!
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.